◼ Archived
Business
Pfizer Signs $1.5 Billion Deal With Blackstone to Fund Weight-Loss-Drug Development
Pfizer secures up to $1.5 billion from Blackstone Life Sciences to advance a once-monthly GLP-1 obesity treatment acquired from Metsera.